Skip to Main Content

Paper Details

Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid receptor.
Nat Commun
6
2023
DNCP, DNCP--NalA, GPCR, GPCR structures, GPCRs, Gi1, KOR, MOR, NalA, kappa-opioid receptor, mice, mu-opioid receptor, naloxamine, pain conditions
Author NameAffiliation
David BakerInstitute for Protein Design, University of Washington
David BakerUniversity of Washington
David BakerHoward Hughes Medical Institute, University of Washington
David BakerInstitute for Protein Design, University of Washington
David BakerUniversity of Washington
David BakerHoward Hughes Medical Institute, University of Washington
  • 1 - 6

Datasets

Release 1.2